Clinical Trials · NCT07675980
Thymosin-α1 for Recurrent Implantation Failure
- Phase
- Phase 2/Phase 3
- Recruitment status
- Recruiting
- Sponsor
- Fakih IVF Fertility Center
- Enrollment
- 136
- Start date
- Feb 2026
- Locations
- 1 site, United Arab Emirates
- Primary endpoint
- Live birth more than 24 weeks